Neuroonkologie
Molekulare Diagnostik und Therapie I

Programm

• 14:45 – 14:55 7 Min. 3 Min.

  • Abstractvortrag

  Establishment of Cell Culture Models from Intracerebral Carcinoma Metastases for Personalized Preclinical Evaluation of Novel Therapeutic Approaches

  • Sebastian Jeising (Düsseldorf)
• 14:55 – 15:05 7 Min. 3 Min.

  • Abstractvortrag

  In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma

  • Sebastian Jeising (Düsseldorf)
• 15:05 – 15:15 7 Min. 3 Min.

  • Abstractvortrag

  Drug repurposing of tonabersat as a potent gap junction inhibitor sensitizes primary glioblastoma cells for temozolomide

  • Anna-Laura Potthoff (Bonn)
• 15:15 – 15:25 7 Min. 3 Min.

  • Abstractvortrag

  Inhibition of intercellular communication via gap junctions renders medulloblastoma cells more susceptible for cytotoxic therapy

  • Matthias Schneider (Bonn)
• 15:25 – 15:35 7 Min. 3 Min.

  • Abstractvortrag

  The Alcatraz-Strategy: A novel multimodal therapeutic approach for glioblastoma

  • Matthias Schneider (Bonn)
• 15:35 – 15:45 7 Min. 3 Min.

  • Abstractvortrag

  [⁶⁸Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [¹⁷⁷Lu]Lu-PSMA therapy in relapsing high-grade glioma

  • Peter Truckenmüller (Berlin)